online_survey_icon_or_logo

Collaboration in Biopharma

pharmafile | October 27, 2017 | Feature | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |  biotech, drugs, pharma, pharmaceutical 

Dear Colleague,

Biopharmaceutical companies are increasingly partnering with a diverse set of health care stakeholders to address scientific and technological challenges – but what makes the most effective collaborative process? We invite you to participate in this short industry-wide survey which seeks to analyse the quality of collaborative processes in the biopharmaceutical industry.

The survey is available here until Wednesday 8 November and, in return, a £5 donation will be made to charity for each completed survey (up to a maximum of £1,000).

Thank you for your time and consideration.

On behalf of CHASE

Related Content

Amphista doses first patient in AML trial of protein degrader

Amphista Therapeutics has dosed the first patient in a phase 1 trial of AMX-883, an …

Digital platform cuts pharmaceutical quality-record approval times by up to 90%

A digital platform for exchanging pharmaceutical quality records between supply-chain partners is now commercially available, …

Agentic commercial: how AI creates dialogue with HCPs and patients to help medicines reach them faster

By Chris Moore Commercial engagement in biopharma used to centre largely on direct conversations between …

The Gateway to Local Adoption Series

Latest content